Abstract
Nitrone exhibits remarkable versatility and applicability in bioorthogonal labeling due to its high reactivity with strained alkynes via the strain-promoted alkyne−nitrone cycloaddition (SPANC) reaction. In this work, cyclometalated iridium(III) complexes bearing two nitrone units were designed as novel phosphorogenic bioorthogonal reagents for bioimaging and phototherapeutics. The complexes showed efficient emission quenching, which is attributed to a nonradiative decay pathway via the low-lying T1/S0 minimum energy crossing point. However, they displayed significant emission enhancement and lifetime extension upon reaction with (1R,8S,9s)-bicyclo[6.1.0]non-4-yne (BCN) derivatives. In particular, they showed a remarkably higher reaction rate toward a bis-cyclooctyne derivative (bis-BCN) compared with its monomeric counterpart (mono-BCN). Cellular studies revealed higher photocytotoxicity of the complexes in bis-BCN-pretreated cells, which is ascribed to the enhanced singlet oxygen (1O2) photosensitization resulting from the elimination of the nitrone-associated quenching pathway. The cross-linking properties and enhanced reactivity of the complexes make them highly promising candidates for the development of photofunctional hydrogels and stapled/cyclized peptides.
Original language | English |
---|---|
Publication status | Published - 17 Mar 2025 |
Event | LSCCB International Conference 2025 for Drug Discovery and Development - Hyatt Regency, Sha Tin, Hong Kong Duration: 17 Mar 2025 → 19 Mar 2025 https://www.lsccb-lc2025.com/ |
Conference
Conference | LSCCB International Conference 2025 for Drug Discovery and Development |
---|---|
Country/Territory | Hong Kong |
City | Sha Tin |
Period | 17/03/25 → 19/03/25 |
Internet address |
Funding
We thank the Hong Kong Research Grants Council (Project Nos. C7075-21GF, CityU 11309423, and HKU 17309220), the Hong Kong Research Grants Council and National Natural Science Foundation of China (Project No. N_CityU104/21), and “Laboratory for Synthetic Chemistry and Chemical Biology” under the Health@InnoHK Program launched by Innovation and Technology Commission, The Government of Hong Kong SAR, P. R. China.